scispace - formally typeset
Open AccessJournal ArticleDOI

Monitoring of endothelial cell activation in experimental sepsis with a two-step cell culture model.

Reads0
Chats0
TLDR
The cell culture model established in this study permits the monitoring of LPS-induced endothelial activation, which plays a central role in sepsis and may serve to assess the effect of mediator modulation by methods such as extracorporeal blood purification.
Abstract
The aim of this work was to establish and characterize a cell culture model for lipopolysaccharide (LPS)-induced activation of human endothelial cells Monocytic THP-1 cells were stimulated for 4 h with 10 ng/ml LPS from Pseudomonas aeruginosa in media containing 10% human plasma Culture supernatants containing LPS and factors secreted by THP-1 in response to stimulation were applied to human umbilical vein endothelial cells (HUVECs) Nuclear factor-κB (NF-κB) activity, expression of adhesion molecules, and cytokine secretion were quantified In addition, the effect of adsorptive removal of tumour necrosis factor-α (TNF-α) from the THP-1 culture supernatant on HUVEC activation was assessed After 4 h of stimulation, THP-1 cells secreted various mediators including TNF-α (854 ± 472 pg/ml), interleukin (IL)-8 (2069 ± 710 pg/ml), IL-18 (305 ± 124 pg/ml), IL-10 (14 ± 5 pg/ml), and IL-1β (24 ± 11 pg/ml) Stimulated HUVECs showed significantly increased NF-κB activity and secreted high amounts of IL-6 and IL-8 Additionally, adhesion molecules ICAM-1 and E-selectin were increased both in the culture supernatant and at the cell surface Removal of TNF-α from the THP-1 culture supernatant prior to HUVEC stimulation resulted in a decrease in NF-κB activity, expression of adhesion molecules, as well as IL-6 secretion The cell culture model established in this study permits the monitoring of LPS-induced endothelial activation, which plays a central role in sepsis and may serve to assess the effect of mediator modulation by methods such as extracorporeal blood purification

read more

Citations
More filters
Journal ArticleDOI

The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases

TL;DR: There is substantial amount of experimental data suggesting that CXCL8 and receptors contribute to elimination of pathogens, but may also contribute significantly to disease-associated processes, including tissue injury, fibrosis, angiogenesis and tumorigenesis.
Journal ArticleDOI

Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide.

TL;DR: It is shown that THP-1 differ from monocytes, PBMC, and whole blood with respect to cytokine release after stimulation with LPS, which supports the concept of extracorporeal mediator modulation as supportive therapy for sepsis.
Journal ArticleDOI

Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin

TL;DR: Evidence is provided that irrespective of their cellular origin, EVs support the propagation of coagulation via the exposure of phosphatidylserine, while the expression of functional tissue factor on EVs appears to be limited to pathological conditions.
Journal ArticleDOI

miR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an In vitro sepsis model.

TL;DR: Evidence is provided for the central role of selected miRNAs in sepsis and their use in the development of small interfering RNA therapeutics to target immune cells and sepsi pathways.
Journal ArticleDOI

Soluble Adhesion Molecules Correlate with Surface Expression in an In Vitro Model of Endothelial Activation

TL;DR: This study supports the use of sCAMs as potential biomarkers of endothelial activation in inflammatory conditions with a significant positive correlation between the levels of ICAM‐1 and sICAM‐ 1 and between the Levels of VCAM and sVCAM‐2 and sE‐selectin seems promising.
References
More filters
Journal ArticleDOI

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

TL;DR: Severe sepsis is a common, expensive, and frequently fatal condition, with as many deaths annually as those from acute myocardial infarction, and is especially common in the elderly and is likely to increase substantially as the U.S. population ages.
Journal ArticleDOI

The Epidemiology of Sepsis in the United States from 1979 through 2000

TL;DR: The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987, and the total in-hospital mortality rate fell, yet the total number of deaths continued to increase.
Journal ArticleDOI

Efficacy and safety of recombinant human activated protein C for severe sepsis.

TL;DR: This phase 3 trial assessed whether treatment with drotrecogin alfa activated reduced the rate of death from any cause among patients with severe sepsis.
Journal ArticleDOI

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

TL;DR: A hypothetical model for staging sepsis is presented, which, in the future, may better characterize the syndrome on the basis of predisposing factors and premorbid conditions, the nature of the underlying infection, the characteristics of the host response, and the extent of the resultant organ dysfunction.
Journal ArticleDOI

Recognition of microorganisms and activation of the immune response.

TL;DR: The mammalian immune system has innate and adaptive components, which cooperate to protect the host against microbial infections, and recent progress brings us closer to an integrated view of the immune system and its function in host defence.
Related Papers (5)